Our new CEO It is with great pleasure we announce the appointment of Philip Kearney as the Chief Executive Officer at Arthritis New Zealand. Philip’s many accomplishments include his roles as Director, Development and Alumni Relations at the University of Otago,...
Arthritis medications need funding too

Arthritis medications need funding too

Arthritis New Zealand today expressed concern that medications that are waiting for Pharmac funding could be overlooked because of publicity about new treatments. Ninety-four medicines are currently waiting for a pharmaceutical schedule listing by Pharmac following...
Page 1 of 812345...Last »

Subscribe To Our eLetter

Join our mailing list to receive the latest news and updates from Arthritis New Zealand

You have Successfully Subscribed!